Physician profile
Stanley Yankelowitz
NPI 1922047497
$2,694.12
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $493 · 2021: $571 · 2022: $625 · 2023: $78.95 · 2024: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $820.58 | 2019-2024 | |
| Glaxosmithkline, LLC. | $316.96 | 2020-2024 | Nucala |
| Astrazeneca Pharmaceuticals Lp | $298.79 | 2019-2022 | |
| Optinose US, INC. | $228.18 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $215.49 | 2019-2020 | |
| Kaleo, INC. | $145.89 | 2020-2022 | |
| Gilead Sciences, INC. | $113.63 | 2019 | |
| Stryker Corporation | $107.22 | 2019-2022 | |
| Acclarent, INC | $72.67 | 2020-2022 | |
| Alk-Abello, INC | $71.95 | 2019-2021 | |
| Csl Behring | $57.90 | 2019-2020 | |
| Aerin Medical INC. | $49.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.95 | 2020 | |
| Medtronic USA, INC. | $29.42 | 2019 | |
| Abbvie INC. | $28.20 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22.70 | 2023 | Sinuva |
| Phadia US INC. | $16.75 | 2019 | |
| Incyte Corporation | $15.25 | 2022 | |
| Amgen INC. | $14.37 | 2022 | |
| Pfizer INC. | $13.85 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.06 | 2019 | |
| Hikma Pharmaceuticals USA | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Yankelowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.